Polypeptide growth factors in bone matrix
- PMID: 3068010
- DOI: 10.1002/9780470513637.ch13
Polypeptide growth factors in bone matrix
Abstract
The presence of many types of polypeptide growth factors in the mineralized extracellular matrix of bone is now well established. These factors are generally referred to as bone-derived growth factors (BDGFs), and are similar, or possibly identical, to the following species; platelet-derived growth factor (PDGF); acidic and basic forms of fibroblast growth factor (aFGF, bFGF); transforming growth factor beta (TGF-beta); and insulin-like growth factor 1 (IGF-1). Several osteoinductive factors, such as bone morphogenetic protein (BMP) and osteogenin, a skeletal growth factor (SGF), and osteoblast-derived BDGFs, have also been identified. Complete description of the biological functions of these BDGFs which are relevant to bone will ultimately require specific bioassays involving specific cell types in vitro, as well as in vivo animal implant models. Studies with primary rat osteoblast-like cells exposed either to mixed BDGFs, pure TGF-beta, or heparin-purified PDGF, aFGF, or bFGF from bovine bone have shown a general dose-dependent mitogenic effect. Phenotypic changes which accompany the BDGF-induced wave of proliferation include: decreased osteocalcin secretion and a reduction in 1,25-(OH)2 vitamin D3-stimulated osteocalcin synthesis; reduced alkaline phosphatase specific activity; decreased cyclic AMP responsiveness to parathyroid hormone (PTH); and increased collagen synthesis. Bone exhibits the most complex spectrum of growth factor activities of any tissue yet described. In bovine bone powder free of blood and cartilage contamination, the volume concentration of mitogens is up to 20 times greater than that in serum. Bone cells and other indigenous cell types must be considered as possible sources of the BDGFs, in addition to sequestration from blood. Mechanisms for the unmasking or release of BDGFs from the mineralized matrix that result in local action on osteoblasts, endothelial cells, and other target cells are undoubtedly important for the development and maintenance of bone tissue.
Similar articles
-
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.J Biol Chem. 1986 Sep 25;261(27):12665-74. J Biol Chem. 1986. PMID: 3745206
-
Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae.Bone. 1988;9(4):243-6. doi: 10.1016/8756-3282(88)90037-3. Bone. 1988. PMID: 3262362
-
Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta.Endocrinology. 1988 Jul;123(1):98-105. doi: 10.1210/endo-123-1-98. Endocrinology. 1988. PMID: 2838270
-
Bone induction by osteogenin and bone morphogenetic proteins.Biomaterials. 1990 Jul;11:33-4. Biomaterials. 1990. PMID: 2204436 Review.
-
Bone growth factors.Clin Orthop Relat Res. 1991 Feb;(263):30-48. Clin Orthop Relat Res. 1991. PMID: 1993386 Review.
Cited by
-
The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.J Orthop Surg Res. 2011 Feb 9;6:8. doi: 10.1186/1749-799X-6-8. J Orthop Surg Res. 2011. PMID: 21306641 Free PMC article.
-
Clec11a/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton.Elife. 2016 Dec 13;5:e18782. doi: 10.7554/eLife.18782. Elife. 2016. PMID: 27976999 Free PMC article.
-
α-Tocopheryl Succinate Inhibits Osteolytic Bone Metastasis of Breast Cancer by Suppressing Migration of Cancer Cells and Receptor Activator of Nuclear Factor-κB Ligand Expression of Osteoblasts.J Bone Metab. 2018 Feb;25(1):23-33. doi: 10.11005/jbm.2018.25.1.23. Epub 2018 Feb 28. J Bone Metab. 2018. PMID: 29564303 Free PMC article.
-
The extracellular regulation of growth factor action.Mol Biol Cell. 1992 Oct;3(10):1057-65. doi: 10.1091/mbc.3.10.1057. Mol Biol Cell. 1992. PMID: 1421565 Free PMC article. Review. No abstract available.
-
The role of bisphosphonates as adjuvant therapy for breast cancer.Curr Oncol Rep. 2001 Nov;3(6):506-15. doi: 10.1007/s11912-001-0072-x. Curr Oncol Rep. 2001. PMID: 11595119 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous